PAB Chart & TA, page-344

Hi all. Been a holder of PAB for a number of years through many ups and downs. Living overseas now. I don't post a whole lot but have seen a fair amount of negative comments of late. I too was very disappointed with the delay. But that's what it is, a delay. If you believe in the stock and the agents, sweet stay around. Biotechs aren't for everyone. Remember that Dr Campbell is a shareholder himself. Remember to check the Top 20 if you are curious about K.Stokes and his position. But if you're honestly buying a stock based on one individual, well.....

The quarterly from 3 months ago indicated that PAT-DX3 was undergoing testing for purity and reproducibility. Although I have only worked for a small oncology company in the past, I can tell you that when we tested our retention samples for the avastin manufactured, they were generally kept for a minimum of 3 months before testing. I expect we're not going to hear results on this till the MCB until after September. Any sooner, that'd be awesome but I wouldn't be holding my breathe.

This is in no way financial advise. DYOR. But I am happy to see how the next few play out with this one. Potential upside with this is good. Good luck to all